The Medicare Advantage program is undergoing its biggest shifts in more than two decades. Payers can take steps now to mount a strategic, agile response as the changes unfold. As Medicare Advantage (MA) payers continue to be buffeted by regulatory and market changes that could dampen margins, payer leaders should not lose sight of the importance of investing now to stabilize their businesses for the long run. A critical area of focus for leaders should be the Medicare Advantage Star Ratings program. While 4+ star performance is becoming table stakes, plans that emphasize achieving better Star-program performance tend to have an advantage.
Read the full article: McKinsey: The Future of Medicare Advantage //
Source: https://www.mckinsey.com/industries/healthcare/our-insights/the-future-of-medicare-advantage